Sorin Group And Orange Business Services To Develop Remote Monitoring Solution For Cardiac Patients
Main Category: Cardiovascular / CardiologyAlso Included In: Medical Devices / Diagnostics
Article Date: 31 Mar 2009 - 5:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Sorin Group (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, and Orange Business Services, the leading global communications solutions integrator, announced an agreement to develop and service a remote monitoring solution for patients implanted with cardiac rhythm management (CRM) devices.
This new solution is based on Sorin's implanted CRM devices' ability to send data to a noninvasive monitoring system located at the patient's home and on Orange Business Services' capabilities to manage the transmission of the data to the physician.
The solution will facilitate the follow-up care of patients by transmitting data electronically from patients' implanted cardiac devices to their physicians, without the patients leaving their homes. Using these data, physicians can detect arrhythmia or cardiac disease progression and provide timely therapy, which may reduce the need for hospitalization and improve the patients' quality of life.
Patients with CRM devices require regular check-ups with their physicians to ensure their devices are functioning properly and the appropriate therapy is being delivered. Managing a growing number of patients implanted with CRM devices, as well as the related follow-up, is increasingly demanding for clinicians. The introduction of a remote monitoring system, which provides caregivers access to comprehensive data recorded by the implanted device while the patient is at home, represents a significant milestone in patient management.
Developed in close collaboration with expert cardiologists, the intelligent discrimination algorithms and data embedded into Sorin Group pacemakers, defibrillators and cardiac resynchronization devices provide caregivers with specific information regarding the device behavior and the patient's condition. These diagnostic capabilities will enable transmission of valuable alert messages, providing clinicians with relevant information and offering patients more peace of mind.
The innovative remote monitoring solution leverages the rich cardiac device knowledge from Sorin Group, the experience in the e-health sector from Orange Healthcare, Orange's division addressing the specific needs of the healthcare market, and a range of innovative communications solutions from Orange Business Services, as well as its vast experience in deploying large and complex integration projects.
"Our strategy is to work with acknowledged leaders in other industries. We are delighted to have signed this collaborative agreement with Orange Business Services, a leading global integrated operator providing pioneering telecommunications services on a worldwide basis. This agreement demonstrates Sorin Group's commitment to continuously enhance the standards of care we deliver to patients and medical professionals," said Stefano Di Lullo, President of the CRM Business Unit of Sorin Group.
"We are pleased to work with a leading company in the cardiovascular medical device industry in order to improve the efficiency and quality of physician-patient relationships," said Thierry Zylberberg, Head of Orange Healthcare. "Sorin Group's advanced medical technologies and innovative therapeutic solutions, combined with Orange's expertise in application and program management for large, complex projects, will result in a solution that increases options to raise the quality of healthcare."
About the Sorin Group
The Sorin Group is a global medical device company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. With 3,500 employees worldwide, the Group focuses on three major therapeutic areas that include: cardiopulmonary bypass (extracorporeal circulation and autotransfusion systems), cardiac rhythm management, and heart valve repair and replacement. Every year, over 1 million patients are treated with the devices of Sorin Group in more than 80 countries.
About Orange
Orange is the key brand of France Telecom, one of the world's leading telecommunications operators. With 123 million customers, the Orange brand now covers Internet, television and mobile services in the majority of countries where the Group operates. At the end of 2008, France Telecom had consolidated sales of 53.5 billion euros and a customer base of more than 182 million customers in 30 countries. These include 122 million mobile customers worldwide and 13 million broadband Internet (ADSL) customers in Europe. Orange is the number three mobile operator and the number one provider of broadband Internet services in Europe and, under the brand Orange Business Services, is one of the world leaders in providing telecommunication services to multinational companies.
The Group's strategy, which is characterized by a strong focus on innovation, convergence and effective cost management, aims to establish Orange as an integrated operator and benchmark for new telecommunications services in Europe. Today the Group remains focused on its core activities as a network operator, while working to develop its position in new growth activities. To meet customer expectations, the Group strives to provide products and services that are simple and user-friendly, while maintaining a sustainable and responsible business model that can be adapted to the requirements of a fast-paced and changing eco-system.
France Telecom (NYSE:FTE) is listed on Euronext Paris (compartment A) and on the New York Stock Exchange.
For more information: http://www.orange.com, http://www.francetelecom.com, http://www.orange-business.com
Orange and any other Orange product or service names included in this material are trademarks of Orange Personal Communications Services Limited, Orange France or France Telecom.
Source
Sorin Group
Visit our cardiovascular / cardiology section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/144335.php>
APA
http://www.medicalnewstoday.com/releases/144335.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




